Works matching IS 13419625 AND DT 2021 AND VI 26 AND IP 1

Results: 26
    1

    Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015  Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 1, p. 1, doi. 10.1007/s10147-020-01818-3
    By:
    • Aogi, Kenjiro;
    • Takeuchi, Hideki;
    • Saeki, Toshiaki;
    • Aiba, Keisuke;
    • Tamura, Kazuo;
    • Iino, Keiko;
    • Imamura, Chiyo K.;
    • Okita, Kenji;
    • Kagami, Yoshikazu;
    • Tanaka, Ryuhei;
    • Nakagawa, Kazuhiko;
    • Fujii, Hirofumi;
    • Boku, Narikazu;
    • Wada, Makoto;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Ohtani, Shoichiro;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il
    Publication type:
    Article
    2
    3
    4

    Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 1, p. 154, doi. 10.1007/s10147-020-01797-5
    By:
    • Kido, Koichi;
    • Hatakeyama, Shingo;
    • Numakura, Kazuyuki;
    • Tanaka, Toshikazu;
    • Oikawa, Masaaki;
    • Noro, Daisuke;
    • Hosogoe, Shogo;
    • Narita, Shintaro;
    • Inoue, Takamitsu;
    • Yoneyama, Takahiro;
    • Ito, Hiroyuki;
    • Nishimura, Shoji;
    • Hashimoto, Yasuhiro;
    • Kawaguchi, Toshiaki;
    • Habuchi, Tomonori;
    • Ohyama, Chikara
    Publication type:
    Article
    5
    6
    7

    Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 1, p. 111, doi. 10.1007/s10147-020-01794-8
    By:
    • Yoshida, Yoichiro;
    • Yamada, Takeshi;
    • Kamiyama, Hirohiko;
    • Kosugi, Chihiro;
    • Ishibashi, Keiichiro;
    • Yoshida, Hiroshi;
    • Ishida, Hideyuki;
    • Yamaguchi, Satoru;
    • Kuramochi, Hidekazu;
    • Fukazawa, Atsuko;
    • Sonoda, Hiromichi;
    • Yoshimatsu, Kazuhiko;
    • Matsuda, Akihisa;
    • Hasegawa, Suguru;
    • Sakamoto, Kazuhiro;
    • Otsuka, Toshiaki;
    • Koda, Keiji
    Publication type:
    Article
    8
    9
    10
    11
    12

    Clinical outcomes and predictive value of programmed cell death-ligand 1 expression in response to anti-programmed cell death 1/ligand 1 antibodies in non-small cell lung cancer patients with performance status 2 or greater.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 1, p. 78, doi. 10.1007/s10147-020-01789-5
    By:
    • Jodai, Takayuki;
    • Saruwatari, Koichi;
    • Ikeda, Tokunori;
    • Moriyama, Eiji;
    • Kashiwabara, Kosuke;
    • Shingu, Naoki;
    • Iyonaga, Kazuhiro;
    • Inaba, Megumi;
    • Ajishi, Yusuke;
    • Honda, Chiharu;
    • Hirosako, Susumu;
    • Maruyama, Hirotaka;
    • Kakiuchi, Yosuke;
    • Eida, Hirofumi;
    • Tomita, Yusuke;
    • Saeki, Sho;
    • Ichiyasu, Hidenori;
    • Sakagami, Takuro
    Publication type:
    Article
    13

    Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 1, p. 51, doi. 10.1007/s10147-020-01788-6
    By:
    • Taguchi, Jun;
    • Shimizu, Yasushi;
    • Ariga, Shin;
    • Goda, Tomohiro;
    • Ohhara, Yoshihito;
    • Honma, Rio;
    • Noguchi, Takuro;
    • Takeuchi, Satoshi;
    • Kinoshita, Ichiro;
    • Amano, Toraji;
    • Mizumachi, Takatsugu;
    • Kano, Satoshi;
    • Takahara, Miki;
    • Abe, Takahisa;
    • Homma, Akihiro;
    • Dosaka-Akita, Hirotoshi
    Publication type:
    Article
    14
    15
    16
    17

    Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 1, p. 169, doi. 10.1007/s10147-020-01784-w
    By:
    • Yamamoto, Yoshiaki;
    • Yatsuda, Junji;
    • Shimokawa, Mototsugu;
    • Fuji, Nakanori;
    • Aoki, Akihiko;
    • Sakano, Shigeru;
    • Yamamoto, Mitsutaka;
    • Suga, Akinobu;
    • Tei, Yasuhide;
    • Yoshihiro, Satoru;
    • Kitahara, Seiji;
    • Nagao, Kazuhiro;
    • Takai, Kimio;
    • Kamiryo, Yoriaki;
    • Akao, Jumpei;
    • Yamaguchi, Shiro;
    • Oba, Kazuo;
    • Shimabukuro, Tomoyuki;
    • Matsumoto, Hiroaki;
    • Kamba, Tomomi
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26